A |
|
ADE |
Adverse Drug Experience (US) |
ADR |
Adverse Drug Reaction |
AE |
Adverse Event (EU), Adverse Experience (US) |
AR |
Assessment Report |
ASMF |
Active Substance Master File |
ASR |
Annual Safety Report |
ATC-Code |
Anatomical Therapeutic Chemical-Code (WHO) |
ATMP |
Advanced Therapy Medicinal Product |
B |
|
BE |
Bioequivalence |
C |
|
(C)CDS |
(Company) Core Data Sheet |
CA |
Competent Authority |
CAPA |
Corrective and Preventive Action |
CBER |
Center for Biologics Evaluation and Research Committee for the evaluation of biologic products at the FDA |
CCSI |
Company Core Safety Information |
CDA |
Confidential Disclosure Agreement |
CDER |
Center for Drug Evaluation and Research |
CFR |
Code of Federal Regulations (US) |
CHMP |
Committee for Medicinal Products for Human Use |
CIOMS |
Council for International Organization of Medical Sciences |
CMD(h) |
Co-ordination Group for Mutual Recognition and Decentralised Procedures – Human |
CMS |
Concerned Member State |
CTD |
Common Technical Document or Clinical Trial Document or Clinical Trials Directive (officially Directive 2001/20/EC) |
CTDMB |
Clinical Trial Data Monitoring Board |
D |
|
DCP |
Decentralised Procedure |
DCSI |
Development Core Safety Information |
DLP |
Data Lock Point |
DMC |
Data Monitoring Committee |
DSMB |
Data Safety Monitoring Board |
E |
|
EBD |
European Birthdate |
EC |
European Commission or Ethics Committee |
E |
|
eCTD |
electronic Common Technical Document |
E |
|
EEA |
European Economic Area |
EEA |
European Economic Area |
EMA |
European Medicines Agency |
EPAR |
European Public Assessment Report |
EU |
European Union |
EudraCT |
European Clinical Trials Database |
EV |
EudraVigilance |
EVCT |
Eudravigilance Clinical Trial Module |
EVMPD |
EudraVigilance Medicinal Product Dictionary |
EVPM |
Eudravigilance Post-Authorisation Module |
EVPRM |
EudraVigilance Product Report Message |
F |
|
FDA |
Food and Drug Administration (US) |
FU(P) |
Follow up |
G |
|
GCP |
Good Clinical Practice |
GL |
Guideline |
GMP |
Good Manufacturing Practice |
GVP |
Guideline on Good Pharmacovigilance Practices |
H |
|
HA |
Health Authority |
HBD |
Harmonised Birth Date |
HMA |
Heads of Medicines Agencies |
HP |
Healthcare Professional |
I |
|
IB |
Investigator’s Brochure |
IBD |
International Birthdate |
IC |
Informed Consent |
ICD |
Informed Consent Document or International Code of Diseases |
ICF |
Informed Consent Form |
ICH |
International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use |
ICH |
International Conference on Harmonization |
ICSR |
Individual Case Safety Report |
IDMB |
Independent Data Monitoring Board |
IMP |
Investigational Medicinal Product |
IND |
Investigational New Drug |
IT |
Information Technology |
L |
|
LLT |
Low Level Term |
LoQ |
List of Questions |
M |
|
M & S |
Marketing & Sales |
MA |
Marketing Authorisation |
MAA |
Marketing Authorisation Applicant |
MAH |
Marketing Authorisation Holder |
MedDRA |
Medical Dictionary for Regulatory Activities |
MFR |
Manufacturer |
MHRA |
Medicines and Healthcare products Regulatory Agency (UK) |
MLM |
Medical Literature Monitoring |
MP |
Medicinal Product |
MRP |
Mutual Recognition Procedure |
MS |
Member State |
MSSO |
Maintenance and Support Services Organization (MedDRA) |
N |
|
N/A |
Not applicable |
NCA |
National Competent Authority |
NDA |
New Drug Approval or New Drug Application |
NS |
Non-serious |
NtA |
Notice to Applicants |
O |
|
OMP |
Orphan Medicinal Product |
OTC |
Over-the-counter (non-prescription medicines) |
P |
|
PA(D)ER |
Periodic Adverse (Drug) Experience Report |
PAES |
Post Authorisation Efficacy Study |
PASS |
Post Authorisation Safety Study |
PBRER |
Periodic Benefit-Risk Evaluation Report |
PhV |
Pharmacovigilance |
PI |
Package Insert or Product Information or Principle Investigator or Parallel Import |
PIP |
Paediatric Investigation Plan |
PK |
Pharmacokinetics |
PL |
Package Leaflet |
PQR |
Product Quality Review |
PRAC |
Pharmacovigilance Risk Assessment Committee |
PSMF |
Pharmacovigilance System Master File |
PSUR |
Periodic Safety Update Report |
PSUSA |
PSUR Single Assessment |
PT |
Preferred Term |
PUMA |
Paediatric Use Marketing Authorisation |
PV |
Pharmacovigilance |
PVA |
Pharmacovigilance Agreement |
Q |
|
QA |
Quality Assurance |
QA |
Quality Assurance |
QC |
Quality Check |
QC |
Quality Check or Quality Control |
QM |
Quality Management |
QP (GMP) |
Qualified Person (Good Manufacturing Practice) |
QPPV |
Qualified Person responsible for Pharmacovigilance |
QRD |
Quality Review of Documents |
R |
|
R & D |
Research & Development |
RA |
Regulatory Affairs or Regulatory Authority |
RAS |
Rapid Alert System |
REG |
Regulation |
RMP |
Risk Management Plan |
RMS |
Reference Member State |
RSI |
Reference Safety Information |
S |
|
SA |
Scientific Advice |
SADR |
Serious Adverse Drug Reaction |
SAE |
Serious Adverse Event |
SC |
Study Coordinator |
SD |
Source Data / Source Document or Single Dose or Standard Deviation |
SDEA |
Safety Data Exchange Agreement |
SDS |
Signal Detection Spreadsheet |
SEQ |
Safety, Efficacy, Quality |
SESAR |
Suspected Expected Serious Adverse Reaction |
SME |
Significant Medical Event or Small and Medium Enterprises |
SMF |
Site Master File |
SmPC |
Summary of Product Characteristics |
SMQ |
Standardised MedDRA Queries |
SOP |
Standard Operating Procedure |
SPC |
Supplementary Protection Certificate |
SRC |
Safety Review Committee |
SUSAR |
Suspected Unexpected Serious Adverse Reaction |
T |
|
TPM |
Third Party Manufacturer |
V |
|
VAERS |
Vaccine Adverse Event Reporting System |
VeDDRA |
Veterinary Dictionary for Drug Related Affairs |
VMP |
Veterinary Medicinal Product |
W |
|
WHO |
World Health Organisation |
WP |
Working Procedure |
X |
|
XEVMPD |
eXtended Eudravigilance Medicinal Product Dictionary |
XML |
Extensible Markup Language |